Korro Bio KRRO
NASDAQ KRRO
$13.18 +0.22 (+1.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Amortizatization of Intangibles (2023 - 2026)

Korro Bio's (KRRO) quarterly Amortizatization of Intangibles came in at -$2000.0 in Q1 2026, down 100.59% YoY from $340000.0 in Q1 2025, and down 109.09% on a QoQ basis from $22000.0 in Q4 2025.

Korro Bio (KRRO) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends

Korro Bio (KRRO) has 4 years of Amortizatization of Intangibles data on file, last reported at -$2000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 100.59% year-over-year to -$2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147000.0 (down 93.07% YoY) and the FY2025 annual result came in at $489000.0, down 72.56% from the prior year.
  • Amortizatization of Intangibles eased to -$2000.0 in Q1 2026, from $22000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $988000.0 in Q3 2024 to a low of -$2000.0 in Q1 2026.
  • A 4-year average of $213545.5 and a median of $68000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 98700.0% — and 2026, when it plunged 100.59%.
  • Tracing KRRO's Amortizatization of Intangibles over 4 years: stood at $1000.0 in 2023, then soared by 62200.0% to $623000.0 in 2024, then slumped by 96.47% to $22000.0 in 2025, then plunged by 109.09% to -$2000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at -$2000.0 (Q1 2026), $22000.0 (Q4 2025), and $47000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Korro Bio 231.77 Mn 116.73 Mn - -1,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Jun 30, 2026 -1,000.00
Mar 31, 2026 -2,000.00
Mar 31, 2026 -2,000.00
Dec 31, 2025 22,000.00
Dec 31, 2025 22,000.00
Sep 30, 2025 47,000.00
Sep 30, 2025 47,000.00
Jun 30, 2025 80,000.00
Jun 30, 2025 80,000.00
Mar 31, 2025 340,000.00
Mar 31, 2025 340,000.00
Dec 31, 2024 623,000.00
Dec 31, 2024 623,000.00
Sep 30, 2024 988,000.00
Sep 30, 2024 988,000.00
Jun 30, 2024 171,000.00
Jun 30, 2024 171,000.00
Sep 30, 2023 1,000.00
Sep 30, 2023 1,000.00